Type XXIII collagen assay
US12391747B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2020 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Dec 18, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/065
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides monoclonal antibodies that target collagen type XXIII, and to immunoassays and kits employing the antibodies for detecting and quantifying the epitope. The invention also provides a method for identifying and monitoring subjects with inflammatory bowel disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.